For cancers of breast, pancreas, prostate, head and neck and colon, the T-ISC phenotype consistently includes surface CD44+ expression (Al Hajj et al, 2003; Hurt et al, 2008; Li et al, 2007; O'Brien et al, 2007; Prince et al, 2007). The gene discussed is CD44; the disease is cancer.